DAIHAN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 023910 for the last quarter is 48.88 B KRW, and it's 0.27% lower compared to the previous quarter. The net income of Q2 24 is 8.02 B KRW.